Skip to main content

Advertisement

SpringerLink
Log in

Incidence of Mucormycosis in a Tertiary Care Hospital During Covid First Wave-A Retrospective Study

  • Original Article
  • Published:
Indian Journal of Otolaryngology and Head & Neck Surgery Aims and scope Submit manuscript

Abstract

Rhino orbital cerebral mucormycosis is a medical emergency; though rare it’s a life threatening infection in patients. It commonly occurs in immunocompromised patients due to various causes. A retrospective study was conducted in tertiary care centre wherein 30 non-covid, diabetic patients were treated for mucormycosis. All underwent intensive debridement and diabetic management along with antifungal- amphotericin. All the cases improved with aggressive therapy: medical and surgical. Early recognition and treatment is needed to prevent morbidity and mortality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Yohai RA, Bullock JD, Aziz AA et al (1994) Survival factors in ROCM major review. Surv Ophthalmol 39:1–3

    Google Scholar 

  2. Ferry AP, Abedi S (1983) Diagnosis and management of ROCM(Phycomycosis): a report of personally observed cases. Ophthalmology 90:1096–104

    Article  CAS  PubMed  Google Scholar 

  3. Pillsbury HC, Fischer ND (1977) Rhino cerebral mucormycosis. Arch otolaryngol 103(4):600–604

    Article  CAS  PubMed  Google Scholar 

  4. Mayer AC (1815) Verschimmelung (Mucedo)imbledenden Korper Duetsches. Arch physiol 1:310–312

    Google Scholar 

  5. Furbinger P (1876) Boebachtungen uber Lungemycose Beim Menshen. Virchows Arch (Pathol Anat) 66:330–365

    Article  Google Scholar 

  6. Baker RD (1957) Mucormycosis - a new disease. JAMA 163:805–808

    Article  CAS  Google Scholar 

  7. Wali U, Balkhair A, AlMunjani A (2012) Cerebro-rhino orbital mucormycosis: an update. J Infect Pub Health. 5(2):116–126

    Article  Google Scholar 

  8. Hibbett DS, Binder MJF, Blackwell BM, Cannon PF et al (2007) A higher- level of phylogenetic classification of the fungi. Mycol Res 111:509–547

    Article  PubMed  Google Scholar 

  9. Kwon Chung J (2012) Taxonomy of fungi causing mucormycosis and entomopthormycosis (Zygomycosis) and nomenclature of the disease and nomenclature of the disease: molecular mycologic perspectives. Clin Inf Dis 54:S8–S15

    Article  Google Scholar 

  10. Roden MM, Zaoutis TE, Buchnanan WL, Knudsen TA, Sarkisova TA, Schaufele RL et al (2005) Epidemiology and outcome of Zygomycosis: a review of 929 reported cases. Clin Infect Dis 41:634–653

    Article  PubMed  Google Scholar 

  11. Ajith Kumar AK, Vikas Gupta, ROCM[Updated 2021 May1]Stat pearls (Internet),Treasure Island(FL)

  12. Cohen SG, Greenberg MS (1980) Rhinomaxillary mucormycosis in a kidney transplant. Oral Surg Oral Med Pathol 50:33–38

    Article  CAS  Google Scholar 

  13. Lunge SB, Sajjan V, Pandit AM (2015) Rhinocerebrocutaneous mucormycosis caused by Mucor species: a rare causation. Indian Dermatol Online J 6(3):189–192

    Article  PubMed  PubMed Central  Google Scholar 

  14. Santosh G Honavar, Editorial-Code Mucor: Guidelines for Diagnosis, Staging and Management of Rhino-orbital-Cerebral Mucormycosis.IJO_1165_21R1_E

  15. Thurtell MJ et al (2013) Neuro ophthalmology of invasive fungal sinusitis: 14 consecutive patients and review of the literature. Clin Exp Ophthal 41(6):567–576

    Article  Google Scholar 

  16. Ribes JA et al (2000) Zygomycetes in human disease. Clin Microbiol Rev 13(2):236–301

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Safder et al (2010) The black turbinate sign: an early MR imaging finding of Nasal Mucormycosis. AJNR Am J Neuroradiol 31(4):772–774

    Article  Google Scholar 

  18. Y kauh,Christie C Nelson,Sharon Felcrat, Ingrid U Scott. Diagnosis and management of orbital mucormycosis. American Academy of Ophthalmology. Eye net magazine. June 2014

  19. Spellberg B, Edwards J, Ibrahim A (2005) Novel perspectives on mucormycosis:pathophysiology, presentation and management. Clin Microbiol Rev 18(3):556–569

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Revenkar SG, Hasan MS, Smith JW (2007) Cure of disseminated zygomycosis with cerebral involvement using high dose liposomal amphotericin B and surgery. Med Mycol 45:183–185

    Article  Google Scholar 

  21. Petrikkos GL (2009) Lipid formulations of amphotericin B as first line of management. Clin Microbiol Infect 15:87–92

    Article  CAS  PubMed  Google Scholar 

  22. Rhino-orbital Mucormycosis: Clinical Findings and treatment Outcomes of four cases. Seyda Karadeniz Ugurlu, Sedat Selim,[…], and Murat Songu. Turk J ophthalmol.2015 Aug;45(4):169–174.

  23. Blitzer A, Lawson M, Meyers BR, Biller HF (1980) Patient survival in paranasal sinus mucormycosis. Laryngoscope 90:635–648

    Article  CAS  PubMed  Google Scholar 

  24. Yohai RA, Bullock JD, Aziz AA, Markert RJ (1994) Survival factors in ROCM. Surviv Ophthalmol 39:3–22

    Article  CAS  Google Scholar 

  25. Bhansali A, Bhadada S, Sharma A et al (2004) Presentation and outcomes of rhino orbital cerebral mucormycosis in patients with diabetes. Post Grad Med J 80:670–674

    Article  CAS  Google Scholar 

  26. Kirdak VR et al (2018) Our experience of 30 cases of mucormycosis of nose and paranasal sinuses. Int J Otorhinolaryngol Head Neck Surg 4(2):490–493

    Article  Google Scholar 

  27. Carlos Zamora R, Hurtarte Sandoval AR (2015) Survival of a rhinocerebral mucormycosis in a ketoacidosis patient. Clin Case Rep Rev. https://doi.org/10.15761/CCRR.1000163

    Article  Google Scholar 

  28. Celis-Aguilar E, Burgos-Páez A et al (2019) An emergent entity: indolent mucormycosis of the paranasal sinuses- a multicenter study. Int Arch Otorhinolaryngol. https://doi.org/10.1055/s-0038-1667005

    Article  PubMed  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

  1. Department of Otorhinolaryngology, Upgraded Institute of Otorhinolaryngology Rajiv Gandhi Government General Hospital, Madras Medical College, Chennai, Tamil Nadu, 600003, India

    Lourdes Albina Siluvai Arulappan

Authors
  1. Lourdes Albina Siluvai Arulappan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lourdes Albina Siluvai Arulappan.

Ethics declarations

Confilct of interest

The authors declare that there is no conflict of interest.

Ethical Approval

Exempt as a retrospective study. Informed consent was obtained from study participants for surgical procedures and use of data for research purpose.

Consent to Participate

Not applicable, as it’s a retrospective study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Siluvai Arulappan, L.A. Incidence of Mucormycosis in a Tertiary Care Hospital During Covid First Wave-A Retrospective Study. Indian J Otolaryngol Head Neck Surg 74 (Suppl 2), 3463–3468 (2022). https://doi.org/10.1007/s12070-021-02786-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12070-021-02786-4

Keywords

Search

Navigation